The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pleuritis (can cause chest pain)
Publications
Nitrofurantoin pulmonary toxicity: neglected threat.
Current drug safety. 2010;5(2):125-8
Recurrent acute nitrofurantoin-induced pulmonary toxicity.
Pharmacotherapy. 2006;26(5):713-8
PLEUROPULMONARY REACTION TO NITROFURANTOIN.
JAMA. 1964;189:239-40
[Acute allergic pulmonary reaction following use of nitrofurantoin].
Nederlands tijdschrift voor geneeskunde. 1980;124(19):751-5
Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976.
European journal of respiratory diseases. 1981;62(3):180-9
Nitrofurantoin pneumonia.
JAMA. 1967;199(10):765-6
Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin.
The New England journal of medicine. 1965;273(22):1185-7
Acute pulmonary sensitivity to nitrofurantoin.
The American journal of roentgenology, radium therapy, and nuclear medicine. 1968;104(4):784-6
Pleuropneumonic reactions to nitrofurantoin.
The New England journal of medicine. 1969;281(20):1087-90
Hospitalizations for pulmonary reactions following nitrofurantoin use.
Chest. 1989;96(3):512-5